Table 3

Survival among 359 873 lung cancer patients according to histological type and surgery

0–1 Month1 Month–1 Year1 Year +
Period of follow-up:HR95% CIp ValueHR95% CIp ValueHR95% CIp Value
NSCLC with surgery (29 670)
SCLC with surgery (incidental) (267)*2.241.453.45<0.0011.651.292.11<0.0011.381.131.680.002
SCLC with surgery (elective) (198)†0.980.462.050.9491.361.001.840.0501.471.181.820.001
NSCLC, no surgery (284 355)5.595.265.94<0.0016.766.576.96<0.0013.303.233.37<0.001
SCLC, no surgery (45 383)6.265.886.67<0.0016.596.396.80<0.0013.893.774.00<0.001
  • Mortality HR adjusted for age, sex, comorbidity and socioeconomic deprivation.

  • *Diagnosis 7 days or less before resection. SCLC probably diagnosed from the resection specimen.

  • †Resection was 8 days or longer after diagnosis. SCLC diagnosis probably known before resection.

  • SCLC, small cell lung cancer; NSCLC, non-small cell lung cancer.